Multi-drug-resistant tuberculosis primary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
Primary prevention in [[tuberculosis]] is targeted to avoid the disease transmission and infection of healthy individuals. The [[BCG]] vaccine is used in children susceptible to [[TB]] infections, such as children living in endemic areas or having a close contact with a confirmed case of [[TB]]. Several preventive measures are used to avoid the transmission of the [[mycobacteria]], such as respiratory isolation, use of respiratory masks among health-care professionals, and advising respiratory hygiene and cough etiquette. | Primary prevention in [[tuberculosis]] is targeted to avoid the disease transmission and infection of healthy individuals. The [[BCG]] vaccine is used in children susceptible to [[TB]] infections, such as children living in endemic areas or having a close contact with a confirmed case of [[TB]]. Several preventive measures are used to avoid the transmission of the [[mycobacteria]], such as respiratory isolation, use of respiratory masks among health-care professionals, and advising respiratory hygiene and cough etiquette. | ||
{{details|Tuberculosis primary prevention}} | {{details|Tuberculosis primary prevention}} | ||
*The most important way to prevent the spread of drug-resistant TB is to take all TB drugs exactly as prescribed by the health care provider. No doses should be missed and treatment should not be stopped early. People receiving treatment for TB disease should tell their health care provider if they are having trouble taking the drugs. | *The most important way to prevent the spread of drug-resistant TB is to take all TB drugs exactly as prescribed by the health care provider. No doses should be missed and treatment should not be stopped early. People receiving treatment for TB disease should tell their health care provider if they are having trouble taking the drugs. | ||
Revision as of 14:00, 30 September 2014
|
Multi-drug-resistant tuberculosis Microchapters |
|
Differentiating Multi-drug-resistant tuberculosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Multi-drug-resistant tuberculosis primary prevention On the Web |
|
American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis primary prevention |
|
Multi-drug-resistant tuberculosis primary prevention in the news |
|
Blogs on Multi-drug-resistant tuberculosis primary prevention |
|
Directions to Hospitals Treating Multi-drug-resistant tuberculosis |
|
Risk calculators and risk factors for Multi-drug-resistant tuberculosis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Primary prevention
Primary prevention in tuberculosis is targeted to avoid the disease transmission and infection of healthy individuals. The BCG vaccine is used in children susceptible to TB infections, such as children living in endemic areas or having a close contact with a confirmed case of TB. Several preventive measures are used to avoid the transmission of the mycobacteria, such as respiratory isolation, use of respiratory masks among health-care professionals, and advising respiratory hygiene and cough etiquette.
- The most important way to prevent the spread of drug-resistant TB is to take all TB drugs exactly as prescribed by the health care provider. No doses should be missed and treatment should not be stopped early. People receiving treatment for TB disease should tell their health care provider if they are having trouble taking the drugs.
- Health care providers can help prevent drug-resistant TB by quickly diagnosing cases, following recommended treatment guidelines, monitoring patients’ response to treatment, and making sure therapy is completed.
- Another way to prevent getting drug-resistant TB is to avoid exposure to known drug-resistant TB patients in closed or crowded places such as hospitals, prisons, or homeless shelters. People who work in hospitals or health-care settings where TB patients are likely to be seen should consult infection control or occupational health experts.